Praxis Precision Medicines PRAX

$ 76.99 5.7%

Quarterly report 2024-Q3
added 11-06-2024

Praxis Precision Medicines Financial Statements 2011-2024 | PRAX

Annual Financial Statements Praxis Precision Medicines

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	359 M	13.4 M	836 M	1.87 B	-	-	-	-	-	-	-	-	-
Shares	6.59 M	3.07 M	42.5 M	36.7 M	-	-	-	-	-	-	-	-	-
Historical Prices	54.4	4.37	19.7	55	-	-	-	-	-	-	-	-	-
Net Income	-26.9 M	-41.2 M	-58.6 M	-61.8 M	-35.5 M	-26.5 M	-	-	-	-	-	-	-
Revenue	2.45 M	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-126 M	-215 M	-167 M	-62 M	-35.8 M	-	-	-	-	-	-	-	-
Interest Expense	3.1 M	957 K	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-126 M	-215 M	-167 M	-61.9 M	-35.8 M	-22.7 M	-	-	-	-	-	-	-
Operating Expenses	129 M	215 M	167 M	62 M	35.8 M	22.7 M	-	-	-	-	-	-	-
General and Administrative Expenses	42.1 M	59.9 M	47.1 M	17 M	6.23 M	3.9 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Praxis Precision Medicines

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	18.9 M	18.8 M	13.9 M	8.79 M	9.04 M	4.65 M	3.54 M	49.4 M	45.8 M	45.5 M	45.5 M	45.3 M	44.7 M	41.6 M	38.5 M	38.3 M	1.67 M	1.64 M	1.63 M	1.62 M	1.56 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-51.9 M	-32.7 M	-39.6 M	-	-24.6 M	-34.3 M	-37.5 M	-	-43.9 M	-60.2 M	-68.7 M	-58.6 M	-44.7 M	-36.4 M	-27.4 M	-25.7 M	-16.2 M	-11.6 M	-8.33 M	-	-10.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	302 K	357 K	431 K	-	468 K	781 K	683 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-56.8 M	-37.5 M	-41.9 M	-	-25.5 M	-35 M	-38.1 M	-	-44.3 M	-60.4 M	-68.8 M	-	-44.8 M	-36.5 M	-27.4 M	-	-16.2 M	-11.6 M	-8.47 M	-	-10.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	4.92 M	4.81 M	2.33 M	-	884 K	648 K	636 K	-	345 K	200 K	132 K	-	73 K	82 K	46 K	-	1 K	5 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-41.8 M	-	-	-	-38 M	-	-44 M	-60.2 M	-68.8 M	-	-44.7 M	-36.4 M	-27.4 M	-	-16.2 M	-11.6 M	-8.46 M	-	-10.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	57.1 M	37.8 M	42.3 M	-	26 M	35.7 M	38.8 M	-	44.3 M	60.4 M	68.8 M	-	44.8 M	36.5 M	27.4 M	-	16.2 M	11.6 M	8.47 M	-	10.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	15.3 M	10.6 M	15.3 M	-	8.72 M	10.1 M	13.3 M	-	13.9 M	16.8 M	16.2 M	-	11.6 M	10.8 M	9.49 M	-	3.43 M	2.52 M	1.6 M	-	1.31 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency